MTHFR C677T polymorphism and differential methylation status in gastric cancer: An association with Helicobacter pylori infection

Virchows Archiv

Volumn 457, Issue 6, 2010, Pages 627-633

  Neves Filho, Eduardo Henrique Cunha ^a   Alves, Markenia Kelia Santos ^a   Lima, Valeska Portela ^a   Rabenhorst, Silvia Helena Barem ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

DNA methylation; Gastric cancer; Helicobacter pylori; MTHFR C677T

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLOOXYGENASE 2; PROTEIN MLH1;

ADULT; AGED; ALLELE; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; CARCINOGENESIS; CONTROLLED STUDY; CORRELATIONAL STUDY; CPG ISLAND; DNA EXTRACTION; DNA METHYLATION; DNA POLYMORPHISM; FEMALE; GENOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STOMACH ADENOCARCINOMA;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ALLELES; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLOOXYGENASE 2; DNA METHYLATION; DNA, NEOPLASM; FEMALE; GENOTYPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; NUCLEAR PROTEINS; POLYMORPHISM, GENETIC; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 78651267364     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-010-0996-3     Document Type: Article

References (37)

1. Lao-Sirieix P, Caldas C, Fitzgerald RC (2010) Genetic predisposition to gastro-oesophageal cancer. Curr Opin Genet Dev 20 (3):210-217
2. Ministério da Saúde do Brasil. Instituto Nacional de Câncer (2009) Estimativa 2010: incidência de câncer no Brasil. INCA, Rio de Janeiro
3. Cotran RS et al (2000) Robbins-patologia estrutural e funcional. Guanabara Koogan, Rio de Janeiro
4. Choi SW, Mason JB (2000) Folate and carcinogenesis: an integrated scheme. J Nutr 130:129-132
5. Miao X, Xing D, Tan W, Qi J, Lu W, Lin D (2002) Susceptibility to gastric cardia adenocarcinoma and genetic polymorphism in methylenetetrahydrofolate reductase in an at-risk Chinese population. Cancer Epidemiol Biomark Prev 11(11):1454-1458
6. Götze T, Röcken C, Röhl FWet al (2007) Gene polymorphisms of folate metabolizing enzymes and the risk of gastric cancer. Cancer Lett 251(2):228-236
7. Shen H, Xu Y, Zheng Y et al (2001) Polymorphisms of 5, 10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case-control study. Int J Cancer 5:332-336
8. Wang J, Sasco AJ, Fu C et al (2008) Aberrant DNA methylation of P16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism in esophageal squamous cell carcinoma. Cancer Epidemiol Biomark Prev 17(1):118-125
9. Graziano F, Kawakami K, Ruzzo A et al (2006) Methylenetetrahydrofolate reductase 677C/T gene polymorphism, gastric cancer susceptibility and genomic DNA hypomethylation in an at-risk Italian population. Int J Cancer 118(3):628-632
10. Boccia S, Hung R, Ricciardi G et al (2008) Meta- and pooled analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer risk: a huge-GSEC review. Am J Epidemiol 167(5):505-516
11. Perri F, Cotugno R, Piepoli A et al (2007) Aberrant DNA methylation in non-neoplastic gastric mucosa of H. pylori infected patients and effect of eradication. Am J Gastroenterol 102 (7):1361-1371
12. Tahara T, Shibata T, Nakamura M et al (2009) MTHFR 677T carrier influences the methylation status of H. pylori-infected gastric mucosa in older subjects. Dig Dis Sci 54(11):2391-2398
13. Atherton JC (1998) H. pylori virulence factors. Br Med Bull 54 (1):105-120
14. Atherton JC (2006) The pathogenesis of Helicobacter pyloriinduced gastro-duodenal diseases. Annu Rev Pathol 1:63-96
15. Foster GD, Twell DJ (1996) Plant gene isolation: principles and practice. Wiley, England
16. Ferrasi AC, Pinheiro NA, Rabenhorst SH et al (2010) Helicobacter pylori and EBV in gastric carcinomas: methylation status and microsatellite instability. World J Gastroenterol 16(3):312-319
17. Frosst P, Blom HJ, Milos R et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113
18. Kim H, Kim YH, Kim SE, Kim NG, Noh SH, Kim H (2003) Concerted promoter hypermethylation of hMLH1, p16INK4A, and E-cadherin in gastric carcinomas with microsatellite instability. J Pathol 200(1):23-31
19. Shim YH, Kang GH, Ro JY (2000) Correlation of p16 hypermethylation with p16 protein loss in sporadic gastric carcinomas. Lab Invest 80(5):689-695
20. Driessen A, Nafteux P, Lerut T et al (2004) Identical cytokeratin expression pattern CK7+/CK20- in esophageal and cardiac cancer: etiopathological and clinical implications. Mod Pathol 17 (1):49-55
21. Tahara E (2004) Genetic pathways of two types of gastric cancer. IARC Sci Publ 157:327-349
22. Weng YR, Sun DF, Fang JY, Gu WQ, Zhu HY (2006) Folate levels in mucosal tissue but not methylenetetrahydrofolate reductase polymorphisms are associated with gastric carcinogenesis. World J Gastroenterol 12(47):7591-7597
23. Wang LD, Guo RF, Fan ZM et al (2005) Association of methylenetetrahydrofolate reductase and thymidylate synthase promoter polymorphisms with genetic susceptibility to esophageal and cardia cancer in a Chinese high-risk population. Dis Esophagus 18(3):177-184
24. Vo QN, Geradts J, Boudreau DA, Bravo JC, Schneider BG (2002) CDKN2A promoter methylation in gastric adenocarcinomas: clinical variables. Hum Pathol 33(12):1200-1204
25. Ksiaa F, Ziadi S, Amara K, Korbi S, Trimeche M (2009) Biological significance of promoter hypermethylation of tumorrelated genes in patients with gastric carcinoma. Clin Chim Acta 404(2):128-133
26. Sarbia M, Geddert H, Klump B, Kiel S, Iskender E, Gabbert HE (2004) Hypermethylation of tumor suppressor genes (p16INK4A, p14ARF and APC) in adenocarcinomas of the upper gastrointestinal tract. Int J Cancer 111(2):224-228
27. van Rijnsoever M, Grieu F, Elsaleh H, Joseph D, Iacopetta B (2002) Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands. Gut 51(6):797-802
28. Nardone G, Compare D, De Colibus P, de Nucci G, Rocco A (2007) Helicobacter pylori and epigenetic mechanisms underlying gastric carcinogenesis. Dig Dis 25(3):225-229
29. Kitajima Y, Ohtaka K, Mitsuno M et al (2008) Helicobacter pylori infection is an independent risk factor for Runx3 methylation in gastric cancer. Oncol Rep 19(1):197-202
30. Maekita T, Nakazawa K, Mihara M et al (2006) High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res 12(3 Pt 1):989-995
31. Katayama Y, Takahashi M, Kuwayama H (2009) Helicobacter pylori causes runx3 gene methylation and its loss of expression in gastric epithelial cells, which is mediated by nitric oxide produced by macrophages. Biochem Biophys Res Commun 388(3):496-500
32. Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci 93:9821-9826
33. Kang GH, Shim YH, Ro JY (1999) Correlation of methylation of the HMLH1 promoter with lack of expression of HMLH1 in sporadic gastric carcinomas with replication error. Lab Invest 79 (7):903-909
34. Akhtar M, Cheng Y, Magno RM et al (2001) Promoter methylation regulates Helicobacter pylori-stimulated cyclooxygenase-2 expression in gastric epithelial cells. Cancer Res 61(6):2399-2403
35. Lage AP, Godfroid E, Fauconnier A et al (1995) Diagnosis of Helicobacter pylori infection by PCR: comparison with other invasive techniques and detection of cagA gene in gastric biopsy specimens. J Clin Microbiol 33:2752-2756
36. Atherton JC, Cao P, Peek RMJR, Tummuru MK, Blaser MJ, Cover TL (1995) Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 270:17771-17777
37. Domingo D, Alarcon T, Pietro N, Sanchez I, Lopez-Brea M (1999) cagA and vacA status of Spanish Helicobacter pylori clinical isolates. J Clin Microbiol 37:2113-2114